Logo image of RAT.MI

RATTI SPA (RAT.MI) Stock Fundamental Analysis

BIT:RAT - Euronext Milan - IT0004724107 - Common Stock - Currency: EUR

1.98  +0.18 (+10%)

Fundamental Rating

2

RAT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 40 industry peers in the Textiles, Apparel & Luxury Goods industry. The financial health of RAT is average, but there are quite some concerns on its profitability. RAT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

RAT had negative earnings in the past year.
RAT had a positive operating cash flow in the past year.
RAT had positive earnings in 4 of the past 5 years.
Each year in the past 5 years RAT had a positive operating cash flow.
RAT.MI Yearly Net Income VS EBIT VS OCF VS FCFRAT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

1.2 Ratios

RAT's Return On Assets of -1.56% is on the low side compared to the rest of the industry. RAT is outperformed by 75.00% of its industry peers.
The Return On Equity of RAT (-3.15%) is worse than 72.50% of its industry peers.
Industry RankSector Rank
ROA -1.56%
ROE -3.15%
ROIC N/A
ROA(3y)0.84%
ROA(5y)2.39%
ROE(3y)1.91%
ROE(5y)5.6%
ROIC(3y)N/A
ROIC(5y)N/A
RAT.MI Yearly ROA, ROE, ROICRAT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20

1.3 Margins

With a Gross Margin value of 63.99%, RAT perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
RAT's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for RAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y0%
RAT.MI Yearly Profit, Operating, Gross MarginsRAT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

RAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RAT remains at a similar level compared to 1 year ago.
Compared to 5 years ago, RAT has about the same amount of shares outstanding.
The debt/assets ratio for RAT has been reduced compared to a year ago.
RAT.MI Yearly Shares OutstandingRAT.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
RAT.MI Yearly Total Debt VS Total AssetsRAT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

An Altman-Z score of 1.91 indicates that RAT is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of RAT (1.91) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.31 indicates that RAT is not too dependend on debt financing.
RAT has a Debt to Equity ratio of 0.31. This is in the better half of the industry: RAT outperforms 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.91
ROIC/WACCN/A
WACC7.01%
RAT.MI Yearly LT Debt VS Equity VS FCFRAT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

RAT has a Current Ratio of 1.71. This is a normal value and indicates that RAT is financially healthy and should not expect problems in meeting its short term obligations.
RAT has a better Current ratio (1.71) than 70.00% of its industry peers.
A Quick Ratio of 0.84 indicates that RAT may have some problems paying its short term obligations.
The Quick ratio of RAT (0.84) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 0.84
RAT.MI Yearly Current Assets VS Current LiabilitesRAT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

0

3. Growth

3.1 Past

RAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -163.27%.
Looking at the last year, RAT shows a decrease in Revenue. The Revenue has decreased by -2.32% in the last year.
Measured over the past years, RAT shows a decrease in Revenue. The Revenue has been decreasing by -3.41% on average per year.
EPS 1Y (TTM)-163.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.5%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y8.95%
Revenue growth 5Y-3.41%
Sales Q2Q%-0.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RAT.MI Yearly Revenue VS EstimatesRAT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RAT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RAT.MI Price Earnings VS Forward Price EarningsRAT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RAT is valued a bit more expensive than 77.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.02
RAT.MI Per share dataRAT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.60%, RAT has a reasonable but not impressive dividend return.
The stock price of RAT dropped by -20.16% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 3.55, RAT pays a better dividend. On top of this RAT pays more dividend than 85.00% of the companies listed in the same industry.
RAT's Dividend Yield is a higher than the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 3.6%

5.2 History

The dividend of RAT decreases each year by -5.29%.
Dividend Growth(5Y)-5.29%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
RAT.MI Yearly Income VS Free CF VS DividendRAT.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M

More info and screens

RATTI SPA

BIT:RAT (4/15/2025, 7:00:00 PM)

1.98

+0.18 (+10%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.08%
Inst Owner ChangeN/A
Ins Owners16.52%
Ins Owner ChangeN/A
Market Cap54.15M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.6%
Yearly Dividend0.1
Dividend Growth(5Y)-5.29%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.59
P/FCF N/A
P/OCF 9.55
P/B 0.94
P/tB 1.11
EV/EBITDA 17.02
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.21
OCFY10.47%
SpS3.36
BVpS2.11
TBVpS1.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.56%
ROE -3.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.99%
FCFM N/A
ROA(3y)0.84%
ROA(5y)2.39%
ROE(3y)1.91%
ROE(5y)5.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y0%
F-Score4
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 4.86
Cap/Depr 115.49%
Cap/Sales 6.65%
Interest Coverage N/A
Cash Conversion 152.35%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 0.84
Altman-Z 1.91
F-Score4
WACC7.01%
ROIC/WACCN/A
Cap/Depr(3y)121.4%
Cap/Depr(5y)150.51%
Cap/Sales(3y)6.91%
Cap/Sales(5y)7.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-163.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y8.95%
Revenue growth 5Y-3.41%
Sales Q2Q%-0.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-143.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-161.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.04%
OCF growth 3Y-23.36%
OCF growth 5Y-25.38%